Effectiveness of Enfortumab-Vedotin for Right Atrial Metastasis Following Total Cystectomy: A Case Report

恩福妥单抗-维多汀治疗全膀胱切除术后右心房转移的疗效:病例报告

阅读:1

Abstract

Cardiac metastases from bladder cancer are extremely rare and typically associated with a poor prognosis. We here report a case of a 74-year-old woman who had been diagnosed with multiple bladder cancer and later developed pelvic recurrence and multiple bone metastases. Second-line pembrolizumab treatment achieved complete remission. Three years and three months after the second-line pembrolizumab treatment, a routine computed tomography scan revealed a right atrial mass and bilaterally enlarged adrenal glands. Primary tumors were not identified, suggesting that the tumor in the right atrium and the enlargement of the adrenal glands were recurrences of the previous bladder cancer. Enfortumab-vedotin (EV) was chosen as a subsequent treatment. One month after this treatment, the tumor in the right atrium was undetectable and her adrenal glands had shrunk. Her complete response was maintained six months after starting subsequent treatment. To the best of our knowledge, this is the first case report of complete remission of bladder cancer metastasis to the right atrium induced by EV.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。